24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publication dates

Publishers

All regions

Drug Industry, November 2014 Market Reports from Top Publishers

You might be interested in: Therapeutics, Medical Equipment, Cancer, more »


 
1-20 of about 18 000 reports for Drug

Trimurthi Drugs & Pharmaceuticals Ltd

Trimurthi Drugs & Pharmaceuticals Ltd

  • $ 55
  • Company report
  • November 2014
  • by Wright Investors' Service

... Trimurthi drugs & pharmaceuticals ltd a textual analysis of the financial results for trimurthi drugs & pharmaceuticals ltd compared to selected competitors. Also included are quantitative analyses ...

Alembic Pharmaceuticals Limited (APLLTD) - Financial and Strategic SWOT Analysis Review

Alembic Pharmaceuticals Limited (APLLTD) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Infective drugs. It offers active pharmaceutical ingredients and other drugs in the therapeutic areas of anti infectives, cardio vascular, musculoskeletol, erectile dysfunction and gastro intestinal. The company ...

Albert David Limited (Symbol:524075) SWOT Analysis, Strategy, Revenues and Profits

Albert David Limited (Symbol:524075) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... And markets pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs and disposable syringes and needles. It offers products, such as analgesics, anti-inflammatory, antibacterial, anti ...

Ankur Drugs and Pharma Ltd. (ANKURDRUGS) - Financial and Strategic SWOT Analysis Review

Ankur Drugs and Pharma Ltd. (ANKURDRUGS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Manufactures and markets pharmaceuticals formulations to healthcare markets. It offers products through the categories such as general products, cephalosporin products and betalactum products. Ankur drugs ...

Ambalal Sarabhai Enterprises Limited (Symbol:500009) SWOT Analysis, Strategy, Revenues and Profits

Ambalal Sarabhai Enterprises Limited (Symbol:500009) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Research and development center which is engaged in the development of new drugs according to the market requirement. Its product portfolio includes analgesic, anti-inflammatory, anti-infective, nutritional ...

American Bio Medica Corporation (Symbol:ABMC) SWOT Analysis, Strategy, Revenues and Profits

American Bio Medica Corporation (Symbol:ABMC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Rds incup, oralstat, rapid stat and rapid reader. Abmc's rapid one is a test cassette designed to rapidly detect a single drug of abuse in a urine specimen. The company's rapid tox is a clia waived test ...

ASKA Pharmaceutical Co., Ltd. (4514) - Financial and Strategic SWOT Analysis Review

ASKA Pharmaceutical Co., Ltd. (4514) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... In-house original products with altat and prostal. The company partners with other japanese and overseas companies to develop drugs such as bnp7787, an antineoplastic effect enhancer for antineoplastic ...

Cancer Drug News 17 NOVEMBER 2014

Cancer Drug News 17 NOVEMBER 2014

  • $ 1 114
  • Industry report
  • November 2014
  • by Espicom Business Intelligence

... Cancer drug news 17 november 2014 industry trend analysis - merck kgaa/pfizer alliance is strategic move for both in immuno-oncologyindustry brief - first patient dosed in neuvax+herceptin phase ...

Drug Delivery Insight 17 NOVEMBER 2014

Drug Delivery Insight 17 NOVEMBER 2014

  • $ 1 114
  • Industry report
  • November 2014
  • by Espicom Business Intelligence

... drug delivery insight 17 november 2014 industry trend analysis - catalent increases service offerings with another acquisitionindustry trend analysis - bms interest underlines vitality ...

Hungary Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Hungary Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • November 2014
  • by Business Monitor International

... While seemingly maintaining the longer term saving targets, included smaller than expected planned cuts to drug reimbursement expenditure in 2012 and yet again failed to underpin exactly how the cuts ...

About 27 000 reports for Drug

Download Unlimited Documents from Trusted Public Sources

Drug Industry in Europe

  • 2013 National Report 2012 Data
  • January 2013
    235 pages
  • Drug  

  • Europe  

    United Kingdom  

View report >

71 Companies for Drug

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Abbott Laboratories

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.